REG - Hikma Pharmaceutical - Director/PDMR Shareholding

Hikma PharmaceuticalsAnnouncement

13/05/2020 13:30

RNS Number : 8074M
  
Hikma Pharmaceuticals Plc
  
13 May 2020
  
 

Hikma Pharmaceuticals PLC
Notification and public disclosure of transactions by persons discharging managerial responsibilities
Said Darwazah



1


Details of the person discharging managerial responsibilities / person closely associated




a)


Name


Said Darwazah




2


Reason for the notification




a)


Position/status


Executive Chairman




b)


Initial notification /Amendment


Initial notification




3


Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor




a)


Name


Hikma Pharmaceuticals PLC




b)


LEI


549300BNS685UXH4JI75




4


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted




a)


Description of the financial instrument, type of instrument and identification code


Description: Ordinary shares of 10 pence each
ID Code: GB00B0LCW083




b)


Nature of the transaction
 


Liquidation of HMS Holdings SAL resulting in the disposal of 1,350,000 Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC.  HMS Holdings SAL is defined as a Person Closely Associated with the Executive Chairman, who is a shareholder.




c)


Price(s) and volume(s)


Price(s): £24.50p
Volume(s): 1,350,000




d)


Aggregated information


Aggregated volume: 1,350,000
Price: £24.50p




e)


Date of the transaction


13 May 2020




f)


Place of the transaction


London



 
 
 Mazen Darwazah



1


Details of the person discharging managerial responsibilities / person closely associated




a)


Name


Mazen Darwazah




2


Reason for the notification




a)


Position/status


Executive Vice Chairman




b)


Initial notification /Amendment


Initial notification




3


Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor




a)


Name


Hikma Pharmaceuticals PLC




b)


LEI


549300BNS685UXH4JI75




4


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted




a)


Description of the financial instrument, type of instrument and identification code


Description: Ordinary shares of 10 pence each
ID Code: GB00B0LCW083




b)


Nature of the transaction
 


Liquidation of HMS Holdings SAL resulting in the disposal of 1,350,000 Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC.    HMS Holdings SAL is defined as a Person Closely Associated with the Executive Vice Chairman, who is a shareholder.




c)


Price(s) and volume(s)


Price(s): £24.50p
Volume(s): 1,350,000




d)


Aggregated information


Aggregated volume: 1,350,000
Price: £24.50p




e)


Date of the transaction


13 May 2020




f)


Place of the transaction


London



 
Peter Speirs

Company Secretary, responsible for releasing this announcement

+44 (0) 20 7399 2760
 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
  END
 
 
DSHBDGDULDBDGGX